Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 637 results for "biocon"

Biocon to list Syngene by selling 15% stake
Business Today India

Biocon Q3 net profit down

Biocon Limited, a biopharmaceutical company, has reported that net profit for the third quarter ended December 31, 2014 was INR910 million, or INR4.6 per share, compared to INR1.05 billion, or INR5.3 per share, for the same quarter ended December ..., 11 hours ago
Biocon (Q3 FY15) India Infoline, 16 hours ago
Biocon : to list Syngene next fiscal 4 Traders, 1 day ago

11 images for biocon

Business Today India, 2 days ago
Money Today, 5 days ago
India TV, 5 days ago, 5 days ago, 5 days ago, 5 days ago
Calcutta Telegraph, 4 days ago
Sify, 5 days ago
Business Standard, 5 days ago
Sify, 5 days ago

Biocon edges higher on govt's plans to support biotech industry

Biocon rose 0.58% to Rs 410.50 at 10:35 IST on BSE after Minister of State Dr. Jitendra Singh yesterday, 27 January 2015, said the government is keen to promote all kinds of upward activities in the biotech sector.
 Business Standard15 hours ago

Biocon posts Rs 779 crore revenue in Q3 FY15

Research services delivers 20 per cent growth In Q3 FY15, Biocon has posted revenues at Rs 779 crore, PAT at Rs 91 crore. The research services has delivered a 20 per cent growth Kiran Mazumdar-Shaw , Chairman and Managing Director, Biocon ...
 Financial Express1 day ago Biocon Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore;  FierceBiotech2 days ago Biocon : Q3 FY15 Revenues at Rs. 779 Crore, PAT at Rs. 91 Crore; Board approves listing Syngene via Offer for Sale  4 Traders5 days ago
Business Standard

Biocon net dips 13%; board approves listing of Syngene

Biopharmaceutical company Biocon has posted a 13% year-on-year decline in net profit for the December quarter to Rs 91 crore, lower than street estimates, largely because of a higher research and development (R&D) spend on global clinical trials.
 Financial Express5 days ago Biocon net dips by 13 % to Rs.91 crore in Q3; inducts two additional independent directors  PharmaBiz5 days ago Biocon reports 13% fall in Q3 consolidated net profit  Indian-Commodity5 days ago Biocon slipped over 3% as Q3 net profit dips to Rs 91 crore  Economic Times5 days ago

Biocon Ltd appoints Additional Independent Directors

Posted On: 2015-01-23 22:43:46 The Board of Directors of Biocon Ltd at its meeting held on January 22, 2015, has appointed Mr. Jeremy Levin and Dr. Vijay Kumar Kuchroo as Additional Independent Directors of the Company. They will hold office up to ...
 Equity Bulls4 days ago Board of Biocon approves appointment of directors  Capital Market5 days ago Board of Biocon approves listing of subsidiary  Capital Market5 days ago Biocon: Outcome of board meeting  Money Control5 days ago

Biocon : a step closer to LatAm foray

Mumbai : Biotechnology firm Biocon plans to enter Latin American and other emerging markets for which regulatory approvals are likely to come in the coming quarters. The company posted a 13% drop in net profit at Rs 91 crore in the quarter ended ...
 4 Traders2 days ago Biocon shares down over 3% as Q3 earnings disappoint  Business Standard5 days ago Biocon shares fall 3%  Hindu Business Line5 days ago Biocon at 1-week high after stake sale in unit  Sify2 weeks ago

22 Quotes from the Most Famous Entrepreneurs

1. Kiran Mazumdar-Shaw, the founder of Biocon "I've had many failures in terms of technological... business... and even research failures. I really believe that entrepreneurship is about being able to face failure, manage failure and succeed ...
 Inc.com2 days ago IN PICS: How Kiran Mazumdar Shaw founded Biocon  Rediff.com2 months ago Govt keen to promote biotech sector: Dr Jitendra  Daily Excelsior.com22 hours ago Scientists, turn to business: Kiran Mazumdar Shaw  The Hindu2 months ago

Biocon To List Its Research Services Unit Syngene

Kiran Mazumdar Shaw led bio-pharma company, Biocon is planning to list its research service subsidiary Syngene divesting 15% stake. The company is said to have initialted talks for appointing investment bankers for the same. If anything to go by ...
 Deal Curry5 days ago Biocon gets nod to initiate process to list Syngene International  Indian-Commodity5 days ago BIOCON : To List Its Research Services Unit Syngene  4 Traders4 days ago

Biocon closer to get nod for LatAm entry

Co looking to derisk Middle East business through newer markets
 DNA4 days ago

BIOCON : R&d spend important for building engines of future

Kiran Mazumdar Shaw , the chairman and managing director of Biocon Limited , has stated that research and development (R&D) spends are important for building engines of future. According to Shaw, ongoing global clinical trials with its ...
 4 Traders1 day ago R&D spend important for building engines of future: Kiran Mazumdar-Shaw, CMD, Biocon  Financial Express5 days ago Biocon chief favours PMO push to propel S&T  Deccan Herald2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
Get updated on latest news & your favorite topics right in your inbox!
More     Less